It is time to expand the fatty liver disease community of practice
Hepatology
.
2023 Nov 1;78(5):1325-1328.
doi: 10.1097/HEP.0000000000000411.
Epub 2023 Jun 23.
Authors
Jeffrey V Lazarus
1
2
3
,
Christopher J Kopka
4
,
Zobair M Younossi
5
6
,
Alina M Allen
7
Affiliations
1
CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, New York, USA.
2
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
3
Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
4
Independent Researcher, Ponte de Lima, Portugal.
5
Department of Medicine, Beatty Liver and Obesity Program, Center for Liver Disease, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.
6
The Global NASH Council, Center for Outcomes Research in Liver Diseases, Washington DC, USA.
7
Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
PMID:
37067242
PMCID:
PMC10581413
DOI:
10.1097/HEP.0000000000000411
No abstract available
MeSH terms
Diabetes Mellitus, Type 2*
Humans
Liver
Non-alcoholic Fatty Liver Disease* / epidemiology
Grants and funding
R03 DK128127/DK/NIDDK NIH HHS/United States